Spiritus Therapeutics was founded on the desire to impact the lives of patients with debilitating diseases who are left with little to no therapeutic options.  Utilizing our combined knowledge regarding the pathology of disease, inflammation and immune senescence alongside the decades of experience within the cell therapy and tissue engineering space we sought to accelerate the pursuit of effective treatment options for patients in need. The Company has successfully leveraged the discovery, technological and clinical success to catalyze regulatory and manufacturing efforts.  The tangible unmet medical need and transformative potential of our target product profile warrant further exploration and development into safe disease modifying therapeutics made accessible to patients through commercialization.